Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Blood Cell Count × Thoracic × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 8 Lymphoid 4 Thoracic 1 Plasma cell 1 Myeloid 1 Head & Neck 1 Breast 1

Conditions

Lung Neoplasms 1

Interventions

Carboplatin 960 Cisplatin 759 Pemetrexed 705 pembrolizumab 519 Paclitaxel 497 Docetaxel 457 Gemcitabine 353 Radiotherapy 337 Erlotinib Hydrochloride 323 Bevacizumab 282 Nivolumab 277 Etoposide 244 durvalumab 223 Drug Therapy 207 osimertinib 197 atezolizumab 187 Radiosurgery 162 Gefitinib 152 Vinorelbine 131 Magnetic Resonance Spectroscopy 116 Ipilimumab 103 130-nm albumin-bound paclitaxel 103 Cetuximab 95 Topotecan 89 Surgical Procedures, Operative 88 Cyclophosphamide 87 Specimen Handling 85 tislelizumab 82 Irinotecan 81 anlotinib 78

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03749512 2018-11-21

NLCR in Prediction of the Grade of Lung Tumor.

Medical University of Silesia

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡